Epigenetics Market Worth $783.17 Million by 2019

This report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global epigenetics market along with the estimates and forecasts of the revenue and market share analysis.

Browse 80 market data tables with 119 figures spread through 200 pages and in-depth TOC on "Epigenetics Market"
http://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html
Early buyers will receive 10% customization on reports.

The global epigenetics market was valued at an estimated $413.24 million in 2014.This market is expected to grow at a CAGR of 13.64% between 2014 and 2019. It is expected to be valued at $783.17 million in 2019.

It is the most widely used technique for cancer research. A large quantity of products such as kits and reagents are required for cancer research. Oncology is the largest research area for the market in 2014. According to GLOBOCAN, in 2012,there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer in 2012 globally.The rapid growth in cancer prevalence, and resultant research interest in oncology, will be primary drivers for the epigenetics market between 2014 and 2019.

Ask For PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=896

The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and reagents. The enzymes product segment is further subsegmented into DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifying enzymes (reverse transcriptases, RNA ligases, and other RNA-modifying enzymes).

The instruments & consumables product segment is further subsegmented into mass spectrometers; next-generation sequencers;qPCRs; sonicators; and other epigenetics instruments & consumables. The kits product segment is further subsegmented into bisulfite conversion kits; ChIP-seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. The reagents product segment is further subsegmented into antibodies; buffers; histones; magnetic beads; primers; and other reagents.

Epigenetics finds applications in a large number of research areas of life sciences. On the basis of research areas, the report is segmented into developmental biology; drug discovery; oncology; and other epigenetics research areas.

On the basis of end users, the global market report is segmented into academic research institutes; biotechnology and pharmaceutical companies; and contract research organizations. The geographic segments included in this report are Asia, Europe, North America, and Rest of the World.

About MarketsandMarkets:
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com